Darrin Disley
CEO at Mogrify Limited
Cambridge, United Kingdom
Writes $100K – $5M checks · typically $1.5M
Find your path to Darrin
228 people in our graph share verified history with Darrin — schools, employers, funds. One of them is your warm intro.
Simon LeveneunlockedDarrin: together at University of Cambridge (1991–1992)
×6Darrin: together at University of Cambridge
Darrin: together at Simprints
×3Darrin: together at Cambridge Judge Business School
About
Darrin Disley is Executive Chairman and Director of Cardiogeni Plc (AQSE: CGNI), a clinical-stage biotechnology company developing cell therapies for heart failure, and has founded, grown, or invested in more than 40 life science, technology, and social enterprises. He previously served as co-founder and CEO of Horizon Discovery Group Plc, taking the company through a $113M IPO on AIM, and as Managing Director of Roquefort Therapeutics Plc. He is an Officer of the Order of the British Empire and holds the Lifetime Queen's Award for Enterprise Promotion.
CEO at Mogrify Limited
Intro paths
→
In turn, Darrin can intro founders to Mogrify Limited's investors below.
Mogrify Limited's investors · 3
Co-founders at Mogrify Limited
Experience
- Cardiogeni PlcExecutive Chairman and Directorcurrent2025 — present
- Coiled Therapeutics plcInterim Managing Director and Director2022 — 2026Greater London
- Sana CapitalAdvisory Board Member2022 — 2025Cambridge
- Carpe Diem Investment FundPrincipal & Founder2008 — 2025Costa Rica
- MogrifyCEO, Director & Investor2019 — 2025Cambridge, United Kingdom
- CelixirChairman, Director & Investor2015 — 2024Stratfor-upon-Avon, United Kingdom
- Footprint Cafes CIOChairman of Trustees & Donor2016 — 2023Cambridge, United Kingdom
- The University of SalfordHonorary Visiting Fellow, School of Environmental and Life Sciences2017 — 2022Salford
- Cambridge Judge Business SchoolHonorary Fellow in Entrepreneurship2016 — 2022Cambridge, United Kingdom
- Cambridge Judge Business SchoolEntrepreneur in Residence2012 — 2016
- University of CambridgeEnterprise Fellow, Department of Chemical Engineering & Biotechnology2013 — 2022
- Carpe Diem C R Lowe Enterprise FundPrincipal & Founder2011 — 2021Cambridge, United Kingdom
- BioIndustry AssociationBoard Member2015 — 2018London, United Kingdom
- HealxDirector & Mentor2015 — 2018Cambridge, United Kingdom
- Cambridge Science CentreTrustee and Executive Council Member2015 — 2018Cambridge, United Kingdom
- SimprintsAdvisory Board Member2015 — 2018Cambridge, United Kingdom
- Axol Bioscience Ltd.Advisory Board Member and Investor2015 — 2018Cambridge
- Biotech and Money Ltd.Advisory Board Member2014 — 2018London, United Kingdom
- BitBioInvestor, Mentor2016 — 2018Cambridge, England, United Kingdom
- Avvinity Therapeutics LimitedCo Founder, Executive Chairman2016 — 2018Cambridge, England, United Kingdom
- Horizon DiscoveryChief Executive Officer and Co-Founder2007 — 2018Cambridge, United Kingdom
- GeoSpock Ltd.Chairman, Co-Founder & Investor2013 — 2018Cambridge, United Kingdom
- Desktop GeneticsChairman and Investor2013 — 2017London, United Kingdom
- Adaptive Profiling LimitedCEO and Co-founder2000 — 2002Cambridge, United Kingdom
- TTP Group plcBioscience Manager1998 — 2000Cambridge, United Kingdom
Skills & more
Executive Team MemberBoard LevelBoard AdministrationExecutive AdvisoryBoard level experienceBiotechnology Industry7Software3Entrepreneurship77Education3Mobile Applications5Investment Advisory5Angel Investing28
+12 more
Board of DirectorsCorporate DevelopmentBusiness PlanningLifesciencesStart-upsBiotechnologyBusiness DevelopmentVenture CapitalManagementStrategyHigh TechTechnology TransferFrom Darrin's professional profile.
Network1
Investors connected to Darrin in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Darrin Disley?
- Darrin Disley is Executive Chairman and Director of Cardiogeni Plc (AQSE: CGNI), a clinical-stage biotechnology company developing cell therapies for heart failure, and has founded, grown, or invested in more than 40 life science, technology, and social enterprises. He previously served as co-founder and CEO of Horizon Discovery Group Plc, taking the company through a $113M IPO on AIM, and as Managing Director of Roquefort Therapeutics Plc. He is an Officer of the Order of the British Empire and holds the Lifetime Queen's Award for Enterprise Promotion.
- Where does Darrin Disley work?
- Darrin Disley is CEO at Mogrify Limited.
- What check size does Darrin Disley write?
- Darrin Disley typically writes checks of $100K – $5M.
- Where did Darrin Disley go to school?
- Darrin Disley studied at University of Cambridge (Doctor of Philosophy (PhD), Biotechnology); The University of Salford (Doctor of Science (Honoris Causa), Business); The University of Salford (Bachelor of Science (BSc), Chemistry).
Same school
Also attended University of Cambridge1,604
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,598 more
Also attended The University of Salford35
Edward LamDirector of Finance at The Spartan GroupEssi HänninenOffice Manager at Innovestor VenturesJim WilkinsonCFO at Oxford Science EnterprisesJoe KellettInvestor at M33 GrowthEdward Vaughan LuiPartner, Head of Impact at Bridges Fund Management Ltd.Ben HarrisonSenior Consultant at Resonance
+ 29 more
Also attended City of Westminster College2
Shared employers
Also worked at Mogrify4
Also worked at Celixir1
Also worked at The University of Salford2
Also worked at Horizon Discovery8
David SmollerGeneral Partner at Cultivation CapitalJonathan MilnerInvestor at Cambridge Innovation CapitalRodrigo SantosEntrepreneur in Residence at Cambridge Innovation CapitalHugo HarrodPartner at MVM Life Science PartnersDr Chris TorranceIndependent Representative of the Investment Advisory Panel at O2h VenturesOliver SimsBio at Octopus Ventures
+ 2 more